224 related articles for article (PubMed ID: 37072474)
41. Identification of key biomarkers and immune infiltration in systemic lupus erythematosus by integrated bioinformatics analysis.
Zhao X; Zhang L; Wang J; Zhang M; Song Z; Ni B; You Y
J Transl Med; 2021 Jan; 19(1):35. PubMed ID: 33468161
[TBL] [Abstract][Full Text] [Related]
42. Characterization of virus-mediated autoimmunity and the consequences for pathological process in patients with systemic lupus erythematosus.
Kim A; Choi SJ; Song GG; Kim JH; Jung JH
Clin Rheumatol; 2023 Oct; 42(10):2799-2809. PubMed ID: 37369873
[TBL] [Abstract][Full Text] [Related]
43. A High Prevalence of Anti-EBNA1 Heteroantibodies in Systemic Lupus Erythematosus (SLE) Supports Anti-EBNA1 as an Origin for SLE Autoantibodies.
Laurynenka V; Ding L; Kaufman KM; James JA; Harley JB
Front Immunol; 2022; 13():830993. PubMed ID: 35251022
[TBL] [Abstract][Full Text] [Related]
44. [Prevalence and clinico-pathological characteristics in patients with Epstein-Barr virus-positive diffuse large B-cell lymphoma in a high complexity hospital in Cali, Columbia].
Amaya D; Moreno JC; Calvache N; Castro A; Pérez B; Silva N
Rev Esp Patol; 2019; 52(3):139-146. PubMed ID: 31213254
[TBL] [Abstract][Full Text] [Related]
45. Diffuse large B-cell lymphoma in a South African cohort with a high HIV prevalence: an analysis by cell-of-origin, Epstein-Barr virus infection and survival.
Cassim S; Antel K; Chetty DR; Oosthuizen J; Opie J; Mohamed Z; Verburgh E
Pathology; 2020 Jun; 52(4):453-459. PubMed ID: 32305135
[TBL] [Abstract][Full Text] [Related]
46. The shared biomarkers and pathways of systemic lupus erythematosus and metabolic syndrome analyzed by bioinformatics combining machine learning algorithm and single-cell sequencing analysis.
Wang Y; Huang Z; Xiao Y; Wan W; Yang X
Front Immunol; 2022; 13():1015882. PubMed ID: 36341378
[TBL] [Abstract][Full Text] [Related]
47. Epstein-Barr virus (EBV) activates NKL homeobox gene HLX in DLBCL.
Nagel S; Uphoff CC; Dirks WG; Pommerenke C; Meyer C; Drexler HG
PLoS One; 2019; 14(5):e0216898. PubMed ID: 31141539
[TBL] [Abstract][Full Text] [Related]
48. Lupus and Epstein-Barr.
James JA; Robertson JM
Curr Opin Rheumatol; 2012 Jul; 24(4):383-8. PubMed ID: 22504579
[TBL] [Abstract][Full Text] [Related]
49. Impaired Cytokine Responses to Epstein-Barr Virus Antigens in Systemic Lupus Erythematosus Patients.
Draborg AH; Sandhu N; Larsen N; Lisander Larsen J; Jacobsen S; Houen G
J Immunol Res; 2016; 2016():6473204. PubMed ID: 27110576
[TBL] [Abstract][Full Text] [Related]
50. Real-Time PCR of cytomegalovirus and Epstein-Barr virus in adult Egyptian patients with systemic lupus erythematosus.
Mohamed AE; Hasen AM; Mohammed GF; Elmaraghy NN
Int J Rheum Dis; 2015 May; 18(4):452-8. PubMed ID: 24341363
[TBL] [Abstract][Full Text] [Related]
51. Epstein-Barr Virus-Positive Diffuse Large B cell Lymphoma in the Experience of a Tertiary Medical Center in Poland.
Ziarkiewicz M; Wołosz D; Dzieciątkowski T; Wilczek E; Dwilewicz-Trojaczek J; Jędrzejczak WW; Gierej B; Ziarkiewicz-Wróblewska B
Arch Immunol Ther Exp (Warsz); 2016 Apr; 64(2):159-69. PubMed ID: 26084760
[TBL] [Abstract][Full Text] [Related]
52. pSTAT3 and MYC in Epstein-Barr virus-positive diffuse large B-cell lymphoma.
Teoh SH; Khoo JJ; Abdul Salam DSD; Peh SC; Cheah SC
Malays J Pathol; 2019 Dec; 41(3):273-281. PubMed ID: 31901912
[TBL] [Abstract][Full Text] [Related]
53. EBV-Positive and EBV-Negative Posttransplant Diffuse Large B Cell Lymphomas Have Distinct Genomic and Transcriptomic Features.
Ferreiro JF; Morscio J; Dierickx D; Vandenberghe P; Gheysens O; Verhoef G; Zamani M; Tousseyn T; Wlodarska I
Am J Transplant; 2016 Feb; 16(2):414-25. PubMed ID: 26780579
[TBL] [Abstract][Full Text] [Related]
54. Clinical Significance of
Ting CY; Chang KM; Kuan JW; Sathar J; Chew LP; Wong OJ; Yusuf Y; Wong L; Samsudin AT; Pana MNBM; Lee SK; Gopal NSR; Puri R; Ong TC; Bahari SK; Goh AS; Teoh CS
Int J Med Sci; 2019; 16(4):556-566. PubMed ID: 31171907
[No Abstract] [Full Text] [Related]
55. Frequent downregulation of BTB and CNC homology 2 expression in Epstein-Barr virus-positive diffuse large B-cell lymphoma.
Noujima-Harada M; Takata K; Miyata-Takata T; Sakurai H; Igarashi K; Ito E; Nagakita K; Taniguchi K; Ohnishi N; Omote S; Tabata T; Sato Y; Yoshino T
Cancer Sci; 2017 May; 108(5):1071-1079. PubMed ID: 28256087
[TBL] [Abstract][Full Text] [Related]
56. Prevalence and clinical implications of epstein-barr virus infection in de novo diffuse large B-cell lymphoma in Western countries.
Ok CY; Li L; Xu-Monette ZY; Visco C; Tzankov A; Manyam GC; Montes-Moreno S; Dybkaer K; Chiu A; Orazi A; Zu Y; Bhagat G; Chen J; Richards KL; Hsi ED; Choi WW; van Krieken JH; Huh J; Ai W; Ponzoni M; Ferreri AJ; Farnen JP; Møller MB; Bueso-Ramos CE; Miranda RN; Winter JN; Piris MA; Medeiros LJ; Young KH
Clin Cancer Res; 2014 May; 20(9):2338-49. PubMed ID: 24583797
[TBL] [Abstract][Full Text] [Related]
57. Bioinformatics analyses of gene expression profile identify key genes and functional pathways involved in cutaneous lupus erythematosus.
Gao ZY; Su LC; Wu QC; Sheng JE; Wang YL; Dai YF; Chen AP; He SS; Huang X; Yan GQ
Clin Rheumatol; 2022 Feb; 41(2):437-452. PubMed ID: 34553293
[TBL] [Abstract][Full Text] [Related]
58. Epstein-Barr virus, cytomegalovirus and BK polyomavirus burden in juvenile systemic lupus erythematosus: correlation with clinical and laboratory indices of disease activity.
Aygun D; Kuskucu MA; Sahin S; Adrovic A; Barut K; Yıldız M; Sharifova S; Midilli K; Cokugras H; Camcıoglu Y; Kasapcopur O
Lupus; 2020 Sep; 29(10):1263-1269. PubMed ID: 32646294
[TBL] [Abstract][Full Text] [Related]
59. Malignant lymphoma in patients with systemic rheumatic disease (rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis, and dermatomyositis): a clinicopathologic study of 24 Japanese cases.
Kojima M; Itoh H; Shimizu K; Saruki N; Murayama K; Higuchi K; Tamaki Y; Matsumoto M; Hirabayashi K; Igarishi S; Masawa N; Nakamura S
Int J Surg Pathol; 2006 Jan; 14(1):43-8. PubMed ID: 16501834
[TBL] [Abstract][Full Text] [Related]
60. EBER-1 positive diffuse large cell lymphoma presenting as lupus nephritis.
Lin MH; Huang JJ; Chen TY; Chen FF; Chang KC; Liu MF; Huang WT; Su WC; Tsao CJ
Lupus; 2003; 12(6):486-9. PubMed ID: 12873053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
